CIBICI   14215
CENTRO DE INVESTIGACION EN BIOQUIMICA CLINICA E INMUNOLOGIA
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
REDUCED TRP-IDO-AHR AXIS ACTIVITY IS ASSOCIATED WITH HIGHER LEVELS OF INFLAMMATORY CYTOKINES IN PATIENTS WITH SEVERE CHRONIC CHAGAS CARDIOMYOPATHY
Autor/es:
VOLPINI, XIMENA; FOZZATTI, LAURA; QUINTANA, FRANCISCO; AMBROSIO, LAURA; THEUMER, MARTIN; CERVI, LAURA; MOTRÁN, CRISTINA; BRAJIN, AGUSTINA; BELOSCAR, JUAN; PEREZ, ANA ROSA
Lugar:
Mar del Plata
Reunión:
Congreso; LXVI Reunión Anual de la Sociedad Argentina de Inmunología; 2018
Institución organizadora:
Sociedad Argentina de Inmunología
Resumen:
After acute infection with T. cruzi approximately 30% of infected individuals develop Chronic Chagas cardiomyopathy (CCC) while the rest remain asymptomatic (Asy). Although the mechanisms underlying the differential progression to CCC are still not fully understood,CCC display a more intense inflammatory response than Asy patients, who appear to have a more regulated immune response. We have reported that the indoleamine 2,3 dioxygenase-tryptophanmetabolites-aryl hydrocarbon receptor (IDO-Trp-AhR) axis is associated with both the development of a strong Th1 response able to control parasite replication and its regulation by inducing, dependingon the levels of AhR activation, Treg or IL-10+ producing cells. AhR can be activated by several ligands many of them being derivatives of Trp, such as L-kynurenine (Kyn) generated by IDO activity. To determine whether IDO-Trp-AhR axis is associated with CCC development,we analyzed the levels of IL-6, TNF, Trp metabolites and AhR agonists in serum samples from healthy controls, CCC and Asy patients by using ELISA, HPLC, targeted LC-MS and AhR agonistic activity. CCC patients were subclassified as Mild (altered ECG without congestive cardiac failure) or Severe (altered ECG, congestive cardiac failure and other alterations). By using a luciferase plasmid reporter assay we detected a decreased global AhR agonistic activity in infected patient sera as compared to healthy controls (p